MT. KISCO, N.Y., Jan. 8, 2014 (GLOBE NEWSWIRE) -- IMMUDYNE, Inc. (OTCQB:IMMD) announced the opening of the Company's new online store, iNRStart.com (http://www.iNRStart.com), for the retail sale of its new naturally derived nutritional supplements; iNR Wellness™, iNR Wellness MD™, and iNR Strength™.
iNRStart.com is recommended by health and wellness experts worldwide and Its flagship products all contain PURACERE™, a clinically researched, doctor-recommended, proprietary compound shown to prime the immune system and support immune health. PURACERE™ has been independently tested, is the purest yeast beta 1,3/1,6 glucan, and contains no yeast by-products, endotoxins, or ash.
Karen Kingston, Chief Marketing Officer of IMMUDYNE, stated, "As the new year begins, millions of individuals commit to improving their overall health and fitness. IMMUDYNE is excited to be able to offer our immune support supplements to consumers worldwide through iNRStart.com. Each iNR Start™ product has been custom formulated for various consumer needs. For example, iNR Strength is formulated for adults who engage in a moderate to intense exercise routine. iNR Strength contains 15mg of PURACERE™ combined with a vitamin B complex to help with overall energy, recovery time, and lean muscle conversion."
Until January 31, 2014, IMMUDYNE is offering a special promotion of 20% off to all new customers who place orders online at www.iNRStart.com, promotion code; START20 (case sensitive). Follow iNR Start at https://www.facebook.com/inrstart and https://twitter.com/inrstart.
IMMUDYNE manufactures and sells proprietary, clinically researched, doctor-recommended, yeast beta-1,3/1,6-D-glucan nutritional supplements and topical skin care products. ImmuDyne has a portfolio of unique proprietary and patent-protected products with applications in the wellness, skin care, anti-aging, fitness, and health markets. Immudyne has offices located in Mt. Kisco, NY, Carlsbad, CA, and Florence, Kentucky. PURACERE, iNR Start, iNR Strength, iNR Wellness, and iNR Wellness MD are trademarks of ImmuDyne, Inc. 2013. Immudyne shares trade under the ticker symbol IMMD and the Company can be found on the web at www.immudyne.com.
Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.
CONTACT: Immudyne, Inc. Mark McLaughlin +1-914-714-8901 MarkMcL@immudyne.comSource:ImmuDyne, Inc.